Importance of weight reduction in type 2 diabetes for the prevention of CVD outcomes: A systematic review of CVOTs.
2型糖尿病減重對心血管疾病結果預防的重要性:心血管臨床試驗的系統性回顧。
Diabetes Res Clin Pract 2024-08-15
Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity.
GLP-1受體激動劑在達到減重和改善超重和肥胖人群心血管結果中的作用。
J Am Heart Assoc 2023-08-01
Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals With Type 2 Diabetes: A Systematic Review.
糖尿病患者體重減輕的系統性回顧:葡萄糖樣肽-1受體激動劑的作用。
Cureus 2023-07-18
Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials.
GLP-1 受體激動劑對血糖控制程度和體重減輕幅度與動脈粥樣硬化心血管疾病風險之關聯:糖尿病心血管結果試驗的系統性回顧和荟萃分析。
Cardiovasc Drugs Ther 2024-01-12
Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta-Regression Analysis.
新型糖尿病藥物對心血管和腎臟結果治療效果的潛在中介因子:一項荟萃回歸分析。
J Am Heart Assoc 2024-04-14
Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
2型糖尿病患者的心血管和腎臟風險:對過度脂肪堆積的當代理解。
Diabetes Care 2024-03-28
The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review.
2型糖尿病患者肥胖症藥物治療的療效:系統性回顧。
Cureus 2024-08-26